Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reinduction chemotherapy for first relapse high-risk neuroblastoma
2012-003092-19Phase 2Completed
- Sponsor
- Italian Association of Pediatric Hematology and Oncology
- Start
- Oct 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan, carboplatin, etoposide, vincristine, doxorubicin and 2 more in neuroblastoma, sponsored by Italian Association of Pediatric Hematology and Oncology. Primary endpoint: Objective Response Rate after four courses. Started Oct 2012; status: completed.
02
Drugs
topotecancarboplatinetoposidevincristinedoxorubicin
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on 2012-003092-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003092-19.